Highlights

[PHARMA] QoQ Quarter Result on 2016-06-30 [#2]

Stock [PHARMA]: PHARMANIAGA BHD
Announcement Date 19-Aug-2016
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2016
Quarter 30-Jun-2016  [#2]
Profit Trend QoQ -     -18.41%    YoY -     -7.54%
Quarter Report


View:


Show?  QoQ % Horiz. %

Quarter Result
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Revenue 618,294 582,816 515,215 531,796 559,195 680,150 524,413 11.59%
  QoQ % 6.09% 13.12% -3.12% -4.90% -17.78% 29.70% -
  Horiz. % 117.90% 111.14% 98.25% 101.41% 106.63% 129.70% 100.00%
PBT 27,777 4,069 19,923 21,487 26,538 23,717 25,337 6.32%
  QoQ % 582.65% -79.58% -7.28% -19.03% 11.89% -6.39% -
  Horiz. % 109.63% 16.06% 78.63% 84.80% 104.74% 93.61% 100.00%
Tax -8,519 -4,969 -7,275 -5,846 -8,068 -7,676 -5,362 36.12%
  QoQ % -71.44% 31.70% -24.44% 27.54% -5.11% -43.16% -
  Horiz. % 158.88% 92.67% 135.68% 109.03% 150.47% 143.16% 100.00%
NP 19,258 -900 12,648 15,641 18,470 16,041 19,975 -2.41%
  QoQ % 2,239.78% -107.12% -19.14% -15.32% 15.14% -19.69% -
  Horiz. % 96.41% -4.51% 63.32% 78.30% 92.47% 80.31% 100.00%
NP to SH 18,923 -836 13,061 14,995 18,379 16,062 19,971 -3.53%
  QoQ % 2,363.52% -106.40% -12.90% -18.41% 14.43% -19.57% -
  Horiz. % 94.75% -4.19% 65.40% 75.08% 92.03% 80.43% 100.00%
Tax Rate 30.67 % 122.12 % 36.52 % 27.21 % 30.40 % 32.36 % 21.16 % 28.05%
  QoQ % -74.89% 234.39% 34.22% -10.49% -6.06% 52.93% -
  Horiz. % 144.94% 577.13% 172.59% 128.59% 143.67% 152.93% 100.00%
Total Cost 599,036 583,716 502,567 516,155 540,725 664,109 504,438 12.13%
  QoQ % 2.62% 16.15% -2.63% -4.54% -18.58% 31.65% -
  Horiz. % 118.75% 115.72% 99.63% 102.32% 107.19% 131.65% 100.00%
Net Worth 544,360 531,169 531,250 524,177 515,906 529,786 534,373 1.24%
  QoQ % 2.48% -0.02% 1.35% 1.60% -2.62% -0.86% -
  Horiz. % 101.87% 99.40% 99.42% 98.09% 96.54% 99.14% 100.00%
Dividend
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Div 10,368 7,773 10,365 12,949 10,354 18,134 23,312 -41.70%
  QoQ % 33.39% -25.01% -19.95% 25.06% -42.90% -22.21% -
  Horiz. % 44.48% 33.34% 44.46% 55.55% 44.42% 77.79% 100.00%
Div Payout % 54.79 % - % 79.37 % 86.36 % 56.34 % 112.90 % 116.73 % -39.58%
  QoQ % 0.00% 0.00% -8.09% 53.28% -50.10% -3.28% -
  Horiz. % 46.94% 0.00% 67.99% 73.98% 48.27% 96.72% 100.00%
Equity
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Net Worth 544,360 531,169 531,250 524,177 515,906 529,786 534,373 1.24%
  QoQ % 2.48% -0.02% 1.35% 1.60% -2.62% -0.86% -
  Horiz. % 101.87% 99.40% 99.42% 98.09% 96.54% 99.14% 100.00%
NOSH 259,219 259,107 259,146 258,981 258,859 259,064 259,027 0.05%
  QoQ % 0.04% -0.02% 0.06% 0.05% -0.08% 0.01% -
  Horiz. % 100.07% 100.03% 100.05% 99.98% 99.94% 100.01% 100.00%
Ratio Analysis
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
NP Margin 3.11 % -0.15 % 2.45 % 2.94 % 3.30 % 2.36 % 3.81 % -12.65%
  QoQ % 2,173.33% -106.12% -16.67% -10.91% 39.83% -38.06% -
  Horiz. % 81.63% -3.94% 64.30% 77.17% 86.61% 61.94% 100.00%
ROE 3.48 % -0.16 % 2.46 % 2.86 % 3.56 % 3.03 % 3.74 % -4.69%
  QoQ % 2,275.00% -106.50% -13.99% -19.66% 17.49% -18.98% -
  Horiz. % 93.05% -4.28% 65.78% 76.47% 95.19% 81.02% 100.00%
Per Share
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
RPS 238.52 224.93 198.81 205.34 216.02 262.54 202.45 11.54%
  QoQ % 6.04% 13.14% -3.18% -4.94% -17.72% 29.68% -
  Horiz. % 117.82% 111.10% 98.20% 101.43% 106.70% 129.68% 100.00%
EPS 7.30 -0.32 5.04 5.79 7.10 6.20 7.71 -3.57%
  QoQ % 2,381.25% -106.35% -12.95% -18.45% 14.52% -19.58% -
  Horiz. % 94.68% -4.15% 65.37% 75.10% 92.09% 80.42% 100.00%
DPS 4.00 3.00 4.00 5.00 4.00 7.00 9.00 -41.73%
  QoQ % 33.33% -25.00% -20.00% 25.00% -42.86% -22.22% -
  Horiz. % 44.44% 33.33% 44.44% 55.56% 44.44% 77.78% 100.00%
NAPS 2.1000 2.0500 2.0500 2.0240 1.9930 2.0450 2.0630 1.19%
  QoQ % 2.44% 0.00% 1.28% 1.56% -2.54% -0.87% -
  Horiz. % 101.79% 99.37% 99.37% 98.11% 96.61% 99.13% 100.00%
Adjusted Per Share Value based on latest NOSH - 261,230
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
RPS 236.69 223.10 197.23 203.57 214.06 260.36 200.75 11.59%
  QoQ % 6.09% 13.12% -3.11% -4.90% -17.78% 29.69% -
  Horiz. % 117.90% 111.13% 98.25% 101.40% 106.63% 129.69% 100.00%
EPS 7.24 -0.32 5.00 5.74 7.04 6.15 7.64 -3.52%
  QoQ % 2,362.50% -106.40% -12.89% -18.47% 14.47% -19.50% -
  Horiz. % 94.76% -4.19% 65.45% 75.13% 92.15% 80.50% 100.00%
DPS 3.97 2.98 3.97 4.96 3.96 6.94 8.92 -41.68%
  QoQ % 33.22% -24.94% -19.96% 25.25% -42.94% -22.20% -
  Horiz. % 44.51% 33.41% 44.51% 55.61% 44.39% 77.80% 100.00%
NAPS 2.0838 2.0333 2.0336 2.0066 1.9749 2.0280 2.0456 1.24%
  QoQ % 2.48% -0.01% 1.35% 1.61% -2.62% -0.86% -
  Horiz. % 101.87% 99.40% 99.41% 98.09% 96.54% 99.14% 100.00%
Price Multiplier on Financial Quarter End Date
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Date 31/03/17 30/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 -
Price 4.8900 5.3000 5.5800 5.5000 5.7600 6.3600 6.5000 -
P/RPS 2.05 2.36 2.81 2.68 2.67 2.42 3.21 -25.82%
  QoQ % -13.14% -16.01% 4.85% 0.37% 10.33% -24.61% -
  Horiz. % 63.86% 73.52% 87.54% 83.49% 83.18% 75.39% 100.00%
P/EPS 66.99 -1,642.66 110.71 94.99 81.13 102.58 84.31 -14.20%
  QoQ % 104.08% -1,583.75% 16.55% 17.08% -20.91% 21.67% -
  Horiz. % 79.46% -1,948.36% 131.31% 112.67% 96.23% 121.67% 100.00%
EY 1.49 -0.06 0.90 1.05 1.23 0.97 1.19 16.15%
  QoQ % 2,583.33% -106.67% -14.29% -14.63% 26.80% -18.49% -
  Horiz. % 125.21% -5.04% 75.63% 88.24% 103.36% 81.51% 100.00%
DY 0.82 0.57 0.72 0.91 0.69 1.10 1.38 -29.30%
  QoQ % 43.86% -20.83% -20.88% 31.88% -37.27% -20.29% -
  Horiz. % 59.42% 41.30% 52.17% 65.94% 50.00% 79.71% 100.00%
P/NAPS 2.33 2.59 2.72 2.72 2.89 3.11 3.15 -18.20%
  QoQ % -10.04% -4.78% 0.00% -5.88% -7.07% -1.27% -
  Horiz. % 73.97% 82.22% 86.35% 86.35% 91.75% 98.73% 100.00%
Price Multiplier on Announcement Date
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Date 16/05/17 21/02/17 21/11/16 19/08/16 13/05/16 15/02/16 26/11/15 -
Price 4.7200 5.1200 5.7000 5.6200 5.6000 6.1900 6.5000 -
P/RPS 1.98 2.28 2.87 2.74 2.59 2.36 3.21 -27.52%
  QoQ % -13.16% -20.56% 4.74% 5.79% 9.75% -26.48% -
  Horiz. % 61.68% 71.03% 89.41% 85.36% 80.69% 73.52% 100.00%
P/EPS 64.66 -1,586.88 113.10 97.06 78.87 99.84 84.31 -16.20%
  QoQ % 104.07% -1,503.08% 16.53% 23.06% -21.00% 18.42% -
  Horiz. % 76.69% -1,882.20% 134.15% 115.12% 93.55% 118.42% 100.00%
EY 1.55 -0.06 0.88 1.03 1.27 1.00 1.19 19.25%
  QoQ % 2,683.33% -106.82% -14.56% -18.90% 27.00% -15.97% -
  Horiz. % 130.25% -5.04% 73.95% 86.55% 106.72% 84.03% 100.00%
DY 0.85 0.59 0.70 0.89 0.71 1.13 1.38 -27.59%
  QoQ % 44.07% -15.71% -21.35% 25.35% -37.17% -18.12% -
  Horiz. % 61.59% 42.75% 50.72% 64.49% 51.45% 81.88% 100.00%
P/NAPS 2.25 2.50 2.78 2.78 2.81 3.03 3.15 -20.08%
  QoQ % -10.00% -10.07% 0.00% -1.07% -7.26% -3.81% -
  Horiz. % 71.43% 79.37% 88.25% 88.25% 89.21% 96.19% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Earn MQ Points while trading with MQ Traders Group
MQ Affiliate
Earn side income from MQ Affiliate Program
 
 

292  614  559  986 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AT 0.095+0.005 
 LCTITAN 2.13-0.27 
 SUPERMX-C1I 0.145-0.005 
 LUSTER 0.165-0.005 
 MAHSING 0.96-0.04 
 HWGB 0.78+0.065 
 DATAPRP 0.195-0.025 
 DGSB 0.225+0.01 
 KSTAR 0.43+0.06 
 MTOUCHE 0.045-0.01 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Supermax: my revised target price - Koon Yew Yin Koon Yew Yin's Blog
2. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
3. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
4. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
5. [Humbled Investor] Supermx - Superb results - Estimation on Next QR Results HumbledInvestor
6. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
7. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
8. Traders Brief 27 Oct 2020 - Volatility Ahead Amid Internal and External Headwinds HLBank Research Highlights
PARTNERS & BROKERS